CD8A and hepatocellular carcinoma: In this respect, in line with previous studies (89–92), these two immune cells (CD8 Tem and CTLs) markedly elucidated the immune characteristics of HCC initiation and progress, which has also shown benefit in improving patient prognosis in both eHCC and aHCC.